Topic Dossier
Generic Versions of Ozempic Coming to India, China, and Canada
First article: 19 mar. 2026, 06:00
|
Last update: 19 mar. 2026, 06:00
|
1 source
|
1 article
Multiple sources. Less manipulation.
Editorial Analysis
Based on 1 source, 1 article
The pharmaceutical landscape is set to change in India, China, and Canada with the introduction of generic versions of Ozempic, a popular drug used for treating diabetes and promoting weight loss. This development is anticipated to significantly reduce the cost of the medication, making it more accessible to a larger segment of the population in these countries. The increased availability of generic Ozempic could also impact the market share of the original brand-name drug.Articles about this topic
Foto: New York Times
Ozempic Is About to Go Generic in India, China and Canada
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Read on New York Times →